Ishitsuka H - Search Results

1

Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.

Sawada N, Ishikawa T, Fukase Y, Nishida M, Yoshikubo T, Ishitsuka H. Sawada N, et al. Among authors: ishitsuka h. Clin Cancer Res. 1998 Apr;4(4):1013-9. Clin Cancer Res. 1998. PMID: 9563897

2

Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues.

Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T, Ishitsuka H. Nishida M, et al. Among authors: ishitsuka h. Biol Pharm Bull. 1996 Nov;19(11):1407-11. doi: 10.1248/bpb.19.1407. Biol Pharm Bull. 1996. PMID: 8951154 Free article.

3

Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.

Ishikawa T, Sekiguchi F, Fukase Y, Sawada N, Ishitsuka H. Ishikawa T, et al. Among authors: ishitsuka h. Cancer Res. 1998 Feb 15;58(4):685-90. Cancer Res. 1998. PMID: 9485021

4

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts.

Ishikawa T, Utoh M, Sawada N, Nishida M, Fukase Y, Sekiguchi F, Ishitsuka H. Ishikawa T, et al. Among authors: ishitsuka h. Biochem Pharmacol. 1998 Apr 1;55(7):1091-7. doi: 10.1016/s0006-2952(97)00682-5. Biochem Pharmacol. 1998. PMID: 9605432

5

Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (capecitabine).

Ishikawa T, Fukase Y, Yamamoto T, Sekiguchi F, Ishitsuka H. Ishikawa T, et al. Among authors: ishitsuka h. Biol Pharm Bull. 1998 Jul;21(7):713-7. doi: 10.1248/bpb.21.713. Biol Pharm Bull. 1998. PMID: 9703255 Free article.

6

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, Shimma N, Umeda I, Ishitsuka H. Miwa M, et al. Among authors: ishitsuka h. Eur J Cancer. 1998 Jul;34(8):1274-81. doi: 10.1016/s0959-8049(98)00058-6. Eur J Cancer. 1998. PMID: 9849491

7

Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.

Endo M, Shinbori N, Fukase Y, Sawada N, Ishikawa T, Ishitsuka H, Tanaka Y. Endo M, et al. Among authors: ishitsuka h. Int J Cancer. 1999 Sep 24;83(1):127-34. doi: 10.1002/(sici)1097-0215(19990924)83:1<127::aid-ijc22>3.0.co;2-6. Int J Cancer. 1999. PMID: 10449619

8

X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts.

Sawada N, Ishikawa T, Sekiguchi F, Tanaka Y, Ishitsuka H. Sawada N, et al. Among authors: ishitsuka h. Clin Cancer Res. 1999 Oct;5(10):2948-53. Clin Cancer Res. 1999. PMID: 10537364

9

Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889.

Endo M, Miwa M, Eda H, Ura M, Tanimura H, Ishikawa T, Miyazaki-Nose T, Hattori K, Shimma N, Yamada-Okabe H, Ishitsuka H. Endo M, et al. Among authors: ishitsuka h. Int J Cancer. 2003 Sep 20;106(5):799-805. doi: 10.1002/ijc.11276. Int J Cancer. 2003. PMID: 12866042

10

Anticachectic activity of 5'-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma.

Tanaka Y, Eda H, Fujimoto K, Tanaka T, Ishikawa T, Ishitsuka H. Tanaka Y, et al. Among authors: ishitsuka h. Cancer Res. 1990 Aug 1;50(15):4528-32. Cancer Res. 1990. PMID: 1695121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters